Evidence map›Paper›PMID 30848026›Full record

ReviewThe Kaohsiung journal of medical sciences2019

From germ theory to germ therapy.

Chieh-Chang Chen, Yen-Nien Chen, Jyh-Ming Liou, Ming-Shiang Wu, Taiwan Gastrointestinal Disease and Helicobacter Consortium

Open access · goldAbstract readReview
In one paragraph

Review in The Kaohsiung journal of medical sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. From germ theory to germ therapy.The Kaohsiung journal of medical sciences · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Chieh-Chang ChenDivision of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Yen-Nien ChenDivision of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Jyh-Ming LiouDivision of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Ming-Shiang WuDivision of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Taiwan Gastrointestinal Disease and Helicobacter Consortium
National Taiwan University · TWNational Taiwan University Hospital · TW

Funding

HTS for Identifying Potential Drug Treatment of Ataxia-TelangiectasiaZIATR000210 · NCATS · NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES · PI MARUGAN, JUAN · 2015 to 2015
$114k
Ministry of Education (MOE) in Taiwan NTU-107 L9014-1Ministry of Health and Welfare of Taiwan MOHW106-TDU-B-211-113 002Ministry of Health and Welfare of Taiwan MOHW107-TDU-B-211-123 002Ministry of Science and Technology, Executive Yuan, ROC, Taiwan MOST 107-3017-F-002-002Ministry of Science and Technology, Executive Yuan, ROC, Taiwan TCTC-TR2 106-2321-B-002-025National Taiwan University Hospital NTUH 104-P05National Taiwan University Hospital NTUH 106-P06Translational Innovation of Biopharmaceutical Development-Technology Supporting Platform Axis 107-0210-01-19-04
6 · The paper itself

Abstract

Germ theory of disease and Koch's postulates has been governing our understanding of the role of microbes in human health since 19th century. The discovery of Helicobacter pylori (H. pylori) and H. pylori associated diseases has typically represented the concept and framework of Koch's postulates. Eradication of H. pylori to prevent peptic ulcers recurrence and gastric cancer is the triumph of this microbiology paradigm. Advances of next generation sequencing provide great insight into the unculturable microbes and show trillions of microbes have evolved with human beings. Research into the microbiome-the microbial communities (microbiota) and the host environment that they inhabit-has changed our understanding about microbes in human health and disease. The gut microbiota, the largest reservoir of the microbiome in human, plays a critical role in our catabolic-metabolism and immunity. This review will show the changes of the view of microbes on human health. We will briefly discuss dysbiosis, the disruption of symbiotic relationship between the host and microbiota, and the associated diseases. This leads to an idea to manipulate the microbiota, either by restoring missing functions or by eliminating harmful functions, to prevent or treat a variety of diseases. Current evidences of two common germ therapies, fecal microbiota transplantation and probiotics, in treating diseases will be reviewed.

Indexed as

Fecal Microbiota TransplantationGerm Theory of DiseaseClinical Trials as TopicDiseaseGastrointestinal MicrobiomeHumansProbioticsfecal microbiota transplantationHelicobacter pylorimicrobiotaprobiotics

Identifiers

PMID30848026
PMCPMC11900695
OpenAlexW2921139938

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.